4th Quarter - Report

DLA PIPER LLP (US) for SANOFI PASTEUR

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Pandemic influenza, vaccine-related issues; H.Res. 295, promoting increased awareness, diagnosis, and treatment of atrial fibrillation to address the high morbidity and mortality rates and to prevent avoidable hospitalizations associated with the disease.

Foreign entity interest: Sanofi SA, interests are those of parent company.

LobbyistCovered position, as disclosed
JILL KELLER —
KEVIN O'SCANNLAIN —
STEVEN R PHILLIPS —
TIFFANI WILLIAMS —

Contacted: Natl Security Council (NSC); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.Res. 295 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.